Thao Vu and Huong Nguyen have become educational and research leaders, driven by their passion for teaching, mentorship, and scientific discovery.
Research shows an improved chance of surviving ICU when patients are cared for in units with more than 75% qualified ICU nursing staff, but there’s a desperate shortage of them.
The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
A review indicates that both cannabinoids and terpenes in cannabis show great promise as antivirals in laboratory research, and could be used to treat infections including COVID-19.
Now that the TGA approved promising medicines, it’s important we get the rollout right to ensure those suffering have access to what could be an important ingredient in solving the mental health crisis.
A class of drugs developed to treat type 2 diabetes and obesity is in short supply, sparking debate about who should be prioritised for access.
An investigation highlighting the failure of some medical journals to maintain rigorous processes amid the rush to publish during the pandemic should serve as a warning to all researchers.
It’s almost comically hypocritical to argue that the Therapeutic Goods Administration needs to ‘loosen up’ in the context of the COVID-19 pandemic.
2022 will be the year we finally have all the means, measures, and tools to control the pandemic to a non-lethal state.
We tend to think of “psychedelics” as illegal, mind-altering substances, but they might just be the key to unlocking a revolution in mental health treatment.
A lot has changed in COVID treatment since the pandemic began. Here are the treatments you can expect — from being diagnosed, to going to hospital, and for those who need to be cared for in ICU.
A new, long-acting formulation of the medication buprenorphine promises to improve the treatment of opioid dependence.
The new variant of interest, detected in 42 countries, possesses a “constellation of mutations that indicate potential properties of immune escape”.
The Morrison government is ramping up its war and security rhetoric, be it COVID or stoking China fears, in an effort to arrest its flagging popularity ahead of the next federal election.
The rapidly-mutating SARS-CoV-2 virus is testing the resilience of the world’s responses, with some variants evolving to become more infectious, and threatening a third wave.
New research recommends Indonesia partner with Australia to develop resilient and responsive healthcare supply chains using modern digital technologies.
The video gaming industry is booming. A Different Lens looks at the good, the bad, and the ugly side of gaming, and the industry's future.
Researchers have discovered that a heart and high blood pressure drug may reduce the spread of breast cancer.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Biotherapeutics in snake venom hold the answer to new medical treatments, and cheaper, more effective snake-bite remedies.
The Collingwood Football Club racism report, and the club’s response to it, is a wake-up call for all of us to reflect more broadly on how we respond to racism.
Addiction remains shrouded in stigma, while the system through which we provide addiction treatment in Australia is fragmented and failing. There's no better time to address these issues.
Doctors rely on independent guidelines when prescribing medication – and Mary Hemming AO is a key figure behind these.
Before COVID-19 began causing sickness, pain and death, a much bigger health threat has been evolving, and desperately needs to be stopped.
Dummy text
